2010
DOI: 10.1016/j.biortech.2009.10.014
|View full text |Cite
|
Sign up to set email alerts
|

Purification and characterization of a novel fibrinolytic enzyme from the polychaete, Neanthes japonica (Iznka)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
18
0
1

Year Published

2013
2013
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 48 publications
(21 citation statements)
references
References 25 publications
2
18
0
1
Order By: Relevance
“…6). This molecular mass is similar to those previously reported for fibrinolytic proteins from other annelids [18,40,41]. Finally, the purified D. sugokai serine protease was not cytotoxic to endothelial cells even when treated at high concentrations (Fig.…”
Section: Discussionsupporting
confidence: 89%
“…6). This molecular mass is similar to those previously reported for fibrinolytic proteins from other annelids [18,40,41]. Finally, the purified D. sugokai serine protease was not cytotoxic to endothelial cells even when treated at high concentrations (Fig.…”
Section: Discussionsupporting
confidence: 89%
“…Therefore, there has been a continual search for safer and cost-effective fibrinolytic agent from diverse sources. To date, fibrinolytic agents have been isolated and characterised from different sources, including plants, animals, microbes and fermented foods (Deng et al 2010; Choi et al 2011). Microbes are considers as a lucrative source of fibrinolytic agents due to their diverse biochemical nature, feasibility of mass culture and ease in genetic manipulation.…”
Section: Introductionmentioning
confidence: 99%
“…The size of the clear hydrolytic zone did not change in the presence of plasminogen, suggesting that protease was a plasmin-like protease, which could directly degrade fibrin but not plasminogen activators such as urokinase (UK), streptokinase (SK), and tissue plasminogen activator (tPA). Therefore, secondary effects such as platelet activation related to plasmin formation could be avoided [20]. This is a specific advantage of serralysin over clinically used plasminogen activators.…”
Section: Discussionmentioning
confidence: 99%